Indaptus Therapeutics (INDP) Misses Q3 EPS by 298c
Tweet
Share
E-mailGet Alerts INDP Hot Sheet
Join SI Premium – FREE
Indaptus Therapeutics (NASDAQ: INDP) reported Q3 EPS of ($2.98).
For earnings history and earnings-related data on Indaptus Therapeutics (INDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- Bill.com Holdings (BILL) PT Raised to $60 at UBS Amid Mixed Underlying Trends
- Guggenheim Reiterates Neutral Rating on CrowdStrike (CRWD)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
